000839896 000__ 01401cam\a2200373Ia\4500
000839896 001__ 839896
000839896 005__ 20210515151453.0
000839896 006__ m\\\\\o\\d\\\\\\\\
000839896 007__ cr\cn\nnnunnun
000839896 008__ 070828s2008\\\\ne\af\\\ob\\\\001\0\eng\d
000839896 010__ $$z  2007035586
000839896 020__ $$z9780123695208
000839896 020__ $$z0123695201
000839896 035__ $$a(MiAaPQ)EBC365589
000839896 035__ $$a(Au-PeEL)EBL365589
000839896 035__ $$a(CaPaEBR)ebr10251256
000839896 035__ $$a(OCoLC)476198605
000839896 040__ $$aMiAaPQ$$cMiAaPQ$$dMiAaPQ
000839896 050_4 $$aRS420$$b.K47 2008
000839896 08204 $$a615/.19$$222
000839896 1001_ $$aKerns, Edward Harvel.
000839896 24510 $$aDrug-like properties$$h[electronic resource] :$$bconcepts, structure design and methods : from ADME to toxicity optimization /$$cEdward H. Kerns and Li Di.
000839896 260__ $$aAmsterdam ;$$aBoston :$$bAcademic Press,$$cc2008.
000839896 300__ $$axix, 526 p., [2] p. of plates :$$bill. (some col.)
000839896 504__ $$aIncludes bibliographical references (p. 492) and index.
000839896 506__ $$aAccess limited to authorized users.
000839896 650_0 $$aPharmaceutical chemistry.
000839896 650_0 $$aDrugs$$xStructure-activity relationships.
000839896 650_0 $$aDrug development.
000839896 650_0 $$aDrugs$$xDesign.
000839896 7001_ $$aDi, Li.
000839896 852__ $$bebk
000839896 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=365589$$zOnline Access
000839896 909CO $$ooai:library.usi.edu:839896$$pGLOBAL_SET
000839896 980__ $$aEBOOK
000839896 980__ $$aBIB
000839896 982__ $$aEbook
000839896 983__ $$aOnline